由端口植入相关的血流感染：一例报告。
Port implantation-related bloodstream infection caused by : A case report.
作者信息
Aminasnafi Ali, Khodavaisy Sadegh, Moslem Maryam, Esmaeilpour Jouneghani Marziye, Sarbandi Fatemeh, Falahatinejad Mahsa, Bashardoust Bahareh, Badali Hamid, Kiasat Neda
机构信息
Health Research Institute, Research Center of Thalassemia & Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Curr Med Mycol. 2023 Mar;9(1):32-35. doi: 10.18502/CMM.2023.150671.
BACKGROUND AND PURPOSE
is a new opportunistic yeast previously named , which belongs to the order Saccharomycetales. Since its discovery, one environmental isolate of has been reported from Myanmar, and one clinical sample from Iran.
CASE REPORT
We report a case of bloodstream infection related to an implantable venous access port. was isolated from patient's blood after chemotherapy, which was meant to control and heal T-cell lymphoblastic lymphoma. Broth dilution minimum inhibitory concentrations were performed according to the CLSI M27-A3 document. The patient recovered with intravenous voriconazole and was discharged with the recommended prescription of oral voriconazole as a maintenance drug.
CONCLUSION
So far, only one case of fungemia has been reported in the world in 2019. This is the second case of bloodstream infection with this yeast from a patient undergoing chemotherapy in Iran.
背景与目的
[具体名称]是一种新的机会性酵母菌，以前称为[曾用名]，属于酵母目。自发现以来，缅甸报告了1株该菌的环境分离株，伊朗报告了1份临床样本。
病例报告
我们报告1例与植入式静脉通路端口相关的血流感染病例。在化疗后从患者血液中分离出[具体名称]，此次化疗旨在控制和治愈T细胞淋巴母细胞淋巴瘤。根据CLSI M27 - A3文件进行肉汤稀释最低抑菌浓度检测。患者接受静脉注射伏立康唑后康复，并出院时携带推荐的口服伏立康唑处方作为维持药物。
结论
到目前为止，2019年全球仅报告了1例[具体名称]真菌血症病例。这是伊朗1例接受化疗患者发生该酵母菌血流感染的第2例病例。
Zotero 插件